This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Peru’s Indecopi launches investigation into pharmaceutical market

( July 16, 2024, 19:20 GMT | Official Statement) -- MLex Summary: Peru’s National Institute for the Defense of Competition and the Protection of Intellectual Property (Indecopi) has initiated proceedings against 15 companies and five individuals for suspected collusion in government drug procurement activities. The conduct occurred between December 2006 and February 2020. The investigation targets 23 tenders related to medications for infections, cancer, and other diseases, and looks at whether the companies coordinated their bids to manipulate auction outcomes and inflate prices.See full document in Spanish:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections